FDA released a new labelling update this week to SGLT-2 inhibitor drug class. Due to the risk of potential ketoacidosis, SGLT-2 inhibitors should be discontinued prior to surgery and reinitiated after surgery once person is able to eat. Specifically, canagliflozin, dapagliflozin and empagliflozin should be discontinued 3 days prior to surgery, and ertugliflozin at least 4 days prior to surgery. For more information, please click below.
Please share your thoughts and subscribe to receive my blogs.
#SGLT-2 inhibitors #discontinuation #surgery
Follow me on Twitter and Facebook @ReecesPiecesDi and Instagram.